secwatch.observer — SEC 8-K summary
======================================

Issuer:     SELECTIS HEALTH, INC. (GBCS)
CIK:        0000727346
Form:       8-K
Filed at:   2024-03-25T23:59:59+00:00
Accession:  0001493152-24-011175
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Selectis Health appoints Adam Desmond as permanent CEO effective March 18, 2024
-------------------------------------------------------------------------------

- Board of Directors appointed Adam Desmond as Chief Executive Officer, effective March 18, 2024.
- Desmond previously served as Interim CEO before this permanent appointment.
- Compensation for Desmond remains unchanged from his interim role.
- No other changes to executive roles or compensation were reported.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/727346/000149315224011175/0001493152-24-011175-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/727346/000149315224011175/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-011175

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer